In Vitro additive effect on griseofulvin and terbinafine combinations against multidrug-resistant dermatophytes

AUTOR(ES)

Lana, Aline Jacobi Dalla, Pippi, Bruna, Carvalho, Anderson Ramos, Moraes, Renata Cougo, Kaiser, Samuel, Ortega, George Gonzalez, Fuentefria, Alexandre Meneghello, Silveira, Gustavo Pozza

FONTE

Braz. J. Pharm. Sci.

DATA DE PUBLICAÇÃO

26/07/2018

RESUMO

ABSTRACT Griseofulvin (GF) and terbinafine (TF) are commonly used drugs to treat dermatophytosis, a fungal infection of the skin. Today there is an increase in drug resistance to these antifungals which highlight the need for alternative synergistic therapies. Minimum Inhibitory Concentration (MIC) of GF and TF were determined against fungi clinical isolates from local hospitals with values ranging 0.03-2.0 µg mL-1 and 0.24-4.0 µg mL-1, respectively. A checkboard test was used to determine the combination of GF:TF which could induce an additive effect against the fungi isolates Multidrug-resistant isolates showed susceptibility after treatment with 16:2 µg mL-1 GF:TF. An MTT assay further verified that GF and TF combinations have greater additive effect against pathological and multidrug-resistant isolates than antifungals alone. Herein we disclose GF:TF combinations that could constitute as a possible new anti-dermatophyte therapy.

Documentos Relacionados

• In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa
• Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli.
• Multidrug-resistant tuberculosis
• In Vitro Activities of Designed Antimicrobial Peptides against Multidrug-Resistant Cystic Fibrosis Pathogens
• Activity of clinafloxacin against multidrug-resistant Enterococcus faecium.